Manchester-based accountants and business advisors RSM Robson Rhodes is celebrating its latest win after being appointed auditors and tax advisors to Controlled Therapeutics (Scotland) Limited (CTS).
The contract was won through RSM’s international network, and fellow members, RSM McGladrey & Pullen, based in Philadelphia following a tender for the audit of Cytokine PharmaSciences Inc in the US. RSM Robson Rhodes was invited to tender for the audit of the UK subsidiary based in Glasgow.
Established in 1987, CTS develop, manufacture and licence pharmaceutical products based on patented drug technologies.
They are the wholly owned subsidiary of Cytokine PharmaSciences Inc, based in Pennsylvania employing 60 people in pharmaceutical research and manufacture.
David Barnes, head of RSM Robson Rhodes, Manchester, comments: “We have been building strong links with our international partners, and we’ve seen a significant increase in the amount of audit work for UK subsidiaries.
“We’re pleased that CTS had the confidence to choose a Manchester firm, this is an exciting opportunity for us.”
Joanne Fletcher-Wall at Bell Pottinger North (01625) 506425
email@example.com or Alex Henshall (01625) 506414 firstname.lastname@example.org
Notes to editor:
RSM Robson Rhodes LLP is a Limited Liability Partnership. The firm practices from nine offices in the UK and Ireland, offering a full range of services to the public and private sectors. As the UK member of the world's sixth largest accounting and consultancy organisation, it is able to call upon the skills and experience of more than 20,000 professionals in over 70 countries. RSM Robson Rhodes is registered to carry on audit work by the Institute of Chartered Accountants in England and Wales and is regulated and authorised by the Financial Services Authority for investment business.